Annual CFO
N/A
December 1, 2024
Summary
- EW annual cash flow from operations is not available.
Performance
EW Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFO
N/A
December 1, 2024
Summary
- EW quarterly cash flow from operations is not available.
Performance
EW Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFO
N/A
December 1, 2024
Summary
- EW TTM cash flow from operations is not available.
Performance
EW TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
EW Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
EW Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Edwards Lifesciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $351.80 M(-5.3%) | $806.40 M(-6.9%) |
| Jun 2024 | - | $371.50 M(-794.4%) | $866.10 M(+64.0%) |
| Mar 2024 | - | -$53.50 M(-139.2%) | $528.20 M(-41.0%) |
| Dec 2023 | $895.80 M(-26.5%) | $136.60 M(-66.8%) | $895.80 M(-14.0%) |
| Sep 2023 | - | $411.50 M(+1124.7%) | $1.04 B(+10.8%) |
| Jun 2023 | - | $33.60 M(-89.3%) | $940.40 M(-24.1%) |
| Mar 2023 | - | $314.10 M(+11.1%) | $1.24 B(+1.7%) |
| Dec 2022 | $1.22 B(-29.7%) | $282.80 M(-8.7%) | $1.22 B(-6.9%) |
| Sep 2022 | - | $309.90 M(-6.7%) | $1.31 B(-14.5%) |
| Jun 2022 | - | $332.20 M(+13.3%) | $1.53 B(-11.2%) |
| Mar 2022 | - | $293.30 M(-21.5%) | $1.72 B(-0.4%) |
| Dec 2021 | $1.73 B(+64.3%) | $373.60 M(-29.8%) | $1.73 B(-1.5%) |
| Sep 2021 | - | $531.90 M(+1.1%) | $1.76 B(+21.9%) |
| Jun 2021 | - | $526.10 M(+75.1%) | $1.44 B(+25.7%) |
| Mar 2021 | - | $300.50 M(-24.8%) | $1.15 B(+8.9%) |
| Dec 2020 | $1.05 B(-10.9%) | $399.80 M(+85.0%) | $1.05 B(-0.3%) |
| Sep 2020 | - | $216.10 M(-6.6%) | $1.06 B(-17.3%) |
| Jun 2020 | - | $231.30 M(+11.7%) | $1.28 B(-7.9%) |
| Mar 2020 | - | $207.10 M(-48.6%) | $1.39 B(+17.4%) |
| Dec 2019 | $1.18 B(+27.6%) | $402.90 M(-7.9%) | $1.18 B(+10.3%) |
| Sep 2019 | - | $437.30 M(+28.2%) | $1.07 B(+9.7%) |
| Jun 2019 | - | $341.20 M(>+9900.0%) | $977.90 M(+25.9%) |
| Mar 2019 | - | $1.50 M(-99.5%) | $776.90 M(-16.2%) |
| Dec 2018 | $926.70 M(-7.4%) | $292.90 M(-14.4%) | $926.70 M(-7.1%) |
| Sep 2018 | - | $342.30 M(+144.2%) | $997.70 M(+3.3%) |
| Jun 2018 | - | $140.20 M(-7.3%) | $966.20 M(-5.6%) |
| Mar 2018 | - | $151.30 M(-58.4%) | $1.02 B(+2.3%) |
| Dec 2017 | $1.00 B(+42.1%) | $363.90 M(+17.1%) | $1.00 B(+19.4%) |
| Sep 2017 | - | $310.80 M(+57.2%) | $837.90 M(+14.3%) |
| Jun 2017 | - | $197.70 M(+54.1%) | $733.00 M(+1.0%) |
| Mar 2017 | - | $128.30 M(-36.2%) | $725.60 M(+3.0%) |
| Dec 2016 | $704.40 M(+28.1%) | $201.10 M(-2.3%) | $704.40 M(+16.0%) |
| Sep 2016 | - | $205.90 M(+8.2%) | $607.10 M(+0.6%) |
| Jun 2016 | - | $190.30 M(+77.7%) | $603.70 M(+3.5%) |
| Mar 2016 | - | $107.10 M(+3.2%) | $583.50 M(+6.1%) |
| Dec 2015 | $549.70 M(-46.2%) | $103.80 M(-48.7%) | $549.70 M(+2.0%) |
| Sep 2015 | - | $202.50 M(+19.0%) | $539.10 M(+54.6%) |
| Jun 2015 | - | $170.10 M(+132.1%) | $348.80 M(-63.5%) |
| Mar 2015 | - | $73.30 M(-21.4%) | $956.70 M(-6.4%) |
| Dec 2014 | $1.02 B(+116.3%) | $93.20 M(+663.9%) | $1.02 B(-1.7%) |
| Sep 2014 | - | $12.20 M(-98.4%) | $1.04 B(-10.3%) |
| Jun 2014 | - | $778.00 M(+460.1%) | $1.16 B(+127.3%) |
| Mar 2014 | - | $138.90 M(+24.8%) | $510.50 M(+8.0%) |
| Dec 2013 | $472.70 M(+30.5%) | $111.30 M(-15.8%) | $472.70 M(-0.7%) |
| Sep 2013 | - | $132.20 M(+3.2%) | $476.10 M(+0.2%) |
| Jun 2013 | - | $128.10 M(+26.7%) | $475.20 M(-3.8%) |
| Mar 2013 | - | $101.10 M(-11.9%) | $493.90 M(+36.4%) |
| Dec 2012 | $362.10 M | $114.70 M(-12.6%) | $362.10 M(+6.3%) |
| Sep 2012 | - | $131.30 M(-10.6%) | $340.80 M(+4.9%) |
| Jun 2012 | - | $146.80 M(-578.2%) | $324.90 M(+23.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | -$30.70 M(-132.9%) | $262.60 M(-14.8%) |
| Dec 2011 | $308.20 M(+22.6%) | $93.40 M(-19.1%) | $308.20 M(-0.2%) |
| Sep 2011 | - | $115.40 M(+36.6%) | $308.80 M(+6.6%) |
| Jun 2011 | - | $84.50 M(+467.1%) | $289.80 M(+14.4%) |
| Mar 2011 | - | $14.90 M(-84.1%) | $253.30 M(+0.8%) |
| Dec 2010 | $251.40 M(+52.1%) | $94.00 M(-2.5%) | $251.40 M(+12.6%) |
| Sep 2010 | - | $96.40 M(+100.8%) | $223.30 M(+12.6%) |
| Jun 2010 | - | $48.00 M(+269.2%) | $198.40 M(-7.4%) |
| Mar 2010 | - | $13.00 M(-80.3%) | $214.30 M(+29.6%) |
| Dec 2009 | $165.30 M(+7.9%) | $65.90 M(-7.8%) | $165.30 M(-8.1%) |
| Sep 2009 | - | $71.50 M(+11.9%) | $179.90 M(+47.2%) |
| Jun 2009 | - | $63.90 M(-277.5%) | $122.20 M(+40.0%) |
| Mar 2009 | - | -$36.00 M(-144.7%) | $87.30 M(-43.0%) |
| Dec 2008 | $153.20 M(-27.1%) | $80.50 M(+483.3%) | $153.20 M(+2.4%) |
| Sep 2008 | - | $13.80 M(-52.4%) | $149.60 M(-23.4%) |
| Jun 2008 | - | $29.00 M(-3.0%) | $195.20 M(-4.3%) |
| Mar 2008 | - | $29.90 M(-61.1%) | $204.00 M(-2.9%) |
| Dec 2007 | $210.20 M(-8.9%) | $76.90 M(+29.5%) | $210.20 M(+3.4%) |
| Sep 2007 | - | $59.40 M(+57.1%) | $203.30 M(-0.4%) |
| Jun 2007 | - | $37.80 M(+4.7%) | $204.10 M(-0.9%) |
| Mar 2007 | - | $36.10 M(-48.4%) | $205.90 M(-10.8%) |
| Dec 2006 | $230.80 M(+68.7%) | $70.00 M(+16.3%) | $230.80 M(+12.5%) |
| Sep 2006 | - | $60.20 M(+52.0%) | $205.10 M(+11.5%) |
| Jun 2006 | - | $39.60 M(-35.1%) | $183.90 M(+4.0%) |
| Mar 2006 | - | $61.00 M(+37.7%) | $176.90 M(+29.3%) |
| Dec 2005 | $136.80 M(-24.3%) | $44.30 M(+13.6%) | $136.80 M(-4.6%) |
| Sep 2005 | - | $39.00 M(+19.6%) | $143.40 M(-12.9%) |
| Jun 2005 | - | $32.60 M(+56.0%) | $164.70 M(+0.2%) |
| Mar 2005 | - | $20.90 M(-58.9%) | $164.30 M(-9.0%) |
| Dec 2004 | $180.60 M(+27.1%) | $50.90 M(-15.6%) | $180.60 M(-17.1%) |
| Sep 2004 | - | $60.30 M(+87.3%) | $217.90 M(+18.4%) |
| Jun 2004 | - | $32.20 M(-13.4%) | $184.00 M(+4.5%) |
| Mar 2004 | - | $37.20 M(-57.8%) | $176.10 M(+23.9%) |
| Dec 2003 | $142.10 M(+17.8%) | $88.20 M(+234.1%) | $142.10 M(+40.6%) |
| Sep 2003 | - | $26.40 M(+8.6%) | $101.10 M(-4.1%) |
| Jun 2003 | - | $24.30 M(+659.4%) | $105.40 M(-15.5%) |
| Mar 2003 | - | $3.20 M(-93.2%) | $124.70 M(+3.4%) |
| Dec 2002 | $120.60 M(+19.4%) | $47.20 M(+53.7%) | $120.60 M(+0.6%) |
| Sep 2002 | - | $30.70 M(-29.6%) | $119.90 M(+3.4%) |
| Jun 2002 | - | $43.60 M(-4944.4%) | $116.00 M(+8.0%) |
| Mar 2002 | - | -$900.00 K(-101.9%) | $107.40 M(+6.3%) |
| Dec 2001 | $101.00 M(-26.3%) | $46.50 M(+73.5%) | $101.00 M(-2.9%) |
| Sep 2001 | - | $26.80 M(-23.4%) | $104.00 M(-13.1%) |
| Jun 2001 | - | $35.00 M(-579.5%) | $119.70 M(+4.4%) |
| Mar 2001 | - | -$7.30 M(-114.7%) | $114.70 M(-16.3%) |
| Dec 2000 | $137.00 M(-22.2%) | $49.50 M(+16.5%) | $137.00 M(+56.6%) |
| Sep 2000 | - | $42.50 M(+41.7%) | $87.50 M(+94.4%) |
| Jun 2000 | - | $30.00 M(+100.0%) | $45.00 M(+200.0%) |
| Mar 2000 | - | $15.00 M | $15.00 M |
| Dec 1999 | $176.00 M | - | - |
FAQ
- What is the all time high annual CFO for Edwards Lifesciences?
- What is the all time high quarterly CFO for Edwards Lifesciences?
- What is the all time high TTM CFO for Edwards Lifesciences?
What is the all time high annual CFO for Edwards Lifesciences?
Edwards Lifesciences all-time high annual cash flow from operations is $1.73 B
What is the all time high quarterly CFO for Edwards Lifesciences?
Edwards Lifesciences all-time high quarterly cash flow from operations is $778.00 M
What is the all time high TTM CFO for Edwards Lifesciences?
Edwards Lifesciences all-time high TTM cash flow from operations is $1.76 B